Public contributions to the development of antibiotics: two successful and two failed investments

Using our established methodology for source identification and funder classification, we uncovered compelling evidence of the essential role played by public and philanthropic funding in antibiotic development. However, there is a significant amount of missing funds-related information. The work we have done on identifying sources for funding can be referenced in support pharmaceutical price negotiations to better reflect the level of public contribution to product development.